v3.26.1
Concentration of Credit and Revenue Risk
 3 Months Ended
Mar. 31, 2026
Risks and Uncertainties [Abstract]  
Concentration of Credit and Revenue Risk Concentration of Credit and Revenue Risk
Our financial instruments that are potentially subject to concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable. While our cash and cash equivalents are managed by reputable financial institutions, the Company’s cash balances with the individual institutions may at times exceed the federally insured limits. At March 31, 2026, substantially all of the Company’s cash and cash equivalents were held at two financial institutions.
The following table provides the Company’s revenue concentrations with respect to payers comprising 10% or more of the Company’s total revenues:
For the Three Months Ended March 31,
20262025
Payer A25 %27 %
Payer B20 %17 %
Payer C17 %15 %

The following table provides the Company’s concentrations of credit risk with respect to payers comprising 10% or more of the Company’s receivables, net:
For the Three Months Ended March 31,
20262025
Payer A51 %48 %
Payer B18 %20 %
Payer C13 %13 %